The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Activated mast cells produce interleukin 13.
Open accessAbstract
When mast cells are activated through their immunoglobulin (Ig)E receptors, release of low molecular weight mediators like histamine is followed by secretion of multiple cytokines, including interleukin (IL)-3, IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor. Here we report that stimulated mast cells also synthesize IL-13 mRNA and protein; secretion of this cytokine may be of particular importance because of its ability to stimulate IgE expression. IL-13 transcripts detected by a semiquantitative reverse transcriptase-mediated polymerase chain reaction assay were induced within 30 min after stimulation of mast cells by dinitrophenyl plus monoclonal IgE anti-dinitrophenyl, and peaked at about 1 h. Within 3 h of IgE stimulation, secreted IL-13 bioactivity, estimated by proliferation of an IL-13-dependent cell line, reached levels equivalent to 1-2 ng/ml of IL-13. When added to human B lymphocytes, the mast cell-derived IL-13 activity (like bone fide IL-13) induced Ig C epsilon transcripts, DNA recombination characteristic of the isotype switch to C epsilon, and the secretion of IgE protein. These results suggest a model of local positive feedback interactions between mast cells and B cells, which could play a role in the pathogenesis of atopy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores
Plaut, M., Pierce, J. H., Watson, C. J., Hanley-Hyde, J., Nordan, R. P., & Paul, W. E. (1989) · Nature · doi:10.1038/339064a0 · Cited by 1,170
Marsh, D. G., Neely, J. D., Breazeale, D. R., Ghosh, B., Freidhoff, L. R., Ehrlich-Kautzky, E., Schou, C., Krishnaswamy, G., & Beaty, T. H. (1994) · Science · doi:10.1126/science.8178175 · Cited by 1,003
New Concepts about the Mast Cell
Flier, J. S., Underhill, L. H., & Galli, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280408 · Cited by 990
Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin
Gordon, J. R., & Galli, S. J. (1990) · Nature · doi:10.1038/346274a0 · Cited by 985
Zurawski, G., & de Vries, J. E. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90021-3 · Cited by 872
Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y., Miyazono, K., Urabe, A., & Takaku, F. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400219 · Cited by 784
Establishment of an immature mast cell line from a patient with mast cell leukemia
Butterfield, J. H., Weiler, D., Dewald, G., & Gleich, G. J. (1988) · Leukemia Research · doi:10.1016/0145-2126(88)90050-1 · Cited by 737
Mast cells as a source of multifunctional cytokines
Gordon, J. R., Burd, P. R., & Galli, S. J. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90176-a · Cited by 696
Self-citationde Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6370 · Cited by 648
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization.
Liu, F., Bohn, J., Ferry, E. L., Yamamoto, H., Molinaro, C. A., Sherman, L. A., Klinman, N. R., & Katz, D. H. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.6.2728 · Cited by 631
Cited by
Fallon, P. G., Ballantyne, S. J., Mangan, N. E., Barlow, J. L., Dasvarma, A., Hewett, D. R., McIlgorm, A., Jolin, H. E., & McKenzie, A. N. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051615 · Cited by 738
Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani, E., Lisignoli, G., Borzì, R. M., & Pulsatelli, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030636 · Cited by 706
Mast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?
Verri, W. A., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 542
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
Sgadari, C., Angiolillo, A., & Tosato, G. (1996) · Blood · doi:10.1182/blood.v87.9.3877.bloodjournal8793877 · Cited by 469
Yoshimoto, T., Tsutsui, H., Tominaga, K., Hoshino, K., Okamura, H., Akira, S., Paul, W. E., & Nakanishi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13962 · Cited by 438
de Saint-Vis, B., Fugier-Vivier, I., Massacrier, C., Gaillard, C., Vanbervliet, B., Aït-Yahia, S., Banchereau, J., Liu, Y.-J., Lebecque, S., & Caux, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1666 · Cited by 427
In vivo expression of IL-12 and IL-13 in atopic dermatitis
Hamid, Q., Naseer, T., Minshall, E. M., Song, Y. L., Boguniewicz, M., & Leung, D. Y. M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70246-4 · Cited by 382
The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
Williams, C. M. M., & Galli, S. J. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106485 · Cited by 355
IL-4 Induces Characteristic Th2 Responses Even in the Combined Absence of IL-5, IL-9, and IL-13
Fallon, P. G., Jolin, H. E., Smith, P., Emson, C. L., Townsend, M. J., Fallon, R., Smith, P., & McKenzie, A. N. J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00332-1 · Cited by 354
McKenzie, G. J., Fallon, P. G., Emson, C. L., Grencis, R. K., & McKenzie, A. N. J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1565 · Cited by 354
Interleukin-4 and lnterleukin-13: Their Similarities and Discrepancies
Chomarat, P., & Banchereau, J. (1998) · International Reviews of Immunology · doi:10.3109/08830189809084486 · Cited by 331
Production of Interleukin 13 by Alveolar Macrophages from Normal and Fibrotic Lung
Hancock, A., Armstrong, L., Gama, R., & Millar, A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.1.2627 · Cited by 275
Loke, P., Gallagher, I., Nair, M. G., Zang, X., Brombacher, F., Mohrs, M., Allison, J. P., & Allen, J. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3926 · Cited by 274
Asthma: pathogenesis and novel drugs for treatment
Olin, J. T., & Wechsler, M. E. (2014) · BMJ · doi:10.1136/bmj.g5517 · Cited by 256
Strategies targeting the IL-4/IL-13 axes in disease
May, R. D., & Fung, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.018 · Cited by 166
Are mast cells instrumental for fibrotic diseases?
Overed-Sayer, C., Rapley, L., Mustelin, T., & Clarke, D. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00174 · Cited by 105
Hauber, H.-P., Bergeron, C., & Hamid, Q. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000078384 · Cited by 90
IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells
Temann, U.-A., Laouar, Y., Eynon, E. E., Homer, R., & Flavell, R. A. (2006) · International Immunology · doi:10.1093/intimm/dxl117 · Cited by 86
Mast-cell responses in the development of asthma
Bingham, C. O., & Austen, K. F. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90056-3 · Cited by 80
PAI1 mediates fibroblast-mast cell interactions in skin fibrosis
Pincha, N., Hajam, E. Y., Badarinath, K., Batta, S. P. R., Masudi, T., Dey, R., Andreasen, P., Kawakami, T., Samuel, R., George, R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99088 · Cited by 70
IgE immunotherapy: A novel concept with promise for the treatment of cancer
Josephs, D. H., Spicer, J. F., Karagiannis, P., Gould, H. J., & Karagiannis, S. N. (2014) · mAbs · doi:10.4161/mabs.27029 · Cited by 58
Metadata
- Authors
- Burd, P. R., Thompson, W. C., Max, E. E., & Mills, F. C.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-04-01
- Volume
- 181
- Issue
- 4
- Pages
- 1373-1380
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2069808501
- Cited by
- 314
- References
- 26
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.